2nd Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 1946 Pharmacy Anti-trust S 1058/HR1971 Pharmacy Competition and Consumer Choice Act Mail service pharmacy

LobbyistCovered position, as disclosed
STACEY FAHRNER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1946 (112th), H.R. 1971 (112th)

Pharmacy PHA

Medical Loss Ratio Interim Final Rule - treatment of PBM transactions with retail pharmacies

LobbyistCovered position, as disclosed
STACEY FAHRNER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.